Global Human Immunodeficiency Virus (HIV) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Human Immunodeficiency Virus (HIV) market size was valued at US$ million in 2023. With growing demand in downstream market, the Human Immunodeficiency Virus (HIV) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Human Immunodeficiency Virus (HIV) market. Human Immunodeficiency Virus (HIV) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Immunodeficiency Virus (HIV). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Immunodeficiency Virus (HIV) market.
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.
Key Features:
The report on Human Immunodeficiency Virus (HIV) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Human Immunodeficiency Virus (HIV) market. It may include historical data, market segmentation by Type (e.g., Diagnosis, Treatment), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Immunodeficiency Virus (HIV) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Immunodeficiency Virus (HIV) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Human Immunodeficiency Virus (HIV) industry. This include advancements in Human Immunodeficiency Virus (HIV) technology, Human Immunodeficiency Virus (HIV) new entrants, Human Immunodeficiency Virus (HIV) new investment, and other innovations that are shaping the future of Human Immunodeficiency Virus (HIV).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Immunodeficiency Virus (HIV) market. It includes factors influencing customer ' purchasing decisions, preferences for Human Immunodeficiency Virus (HIV) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Immunodeficiency Virus (HIV) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Immunodeficiency Virus (HIV) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Immunodeficiency Virus (HIV) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Immunodeficiency Virus (HIV) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Immunodeficiency Virus (HIV) market.
Market Segmentation:
Human Immunodeficiency Virus (HIV) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Human Immunodeficiency Virus (HIV) market size was valued at US$ million in 2023. With growing demand in downstream market, the Human Immunodeficiency Virus (HIV) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Human Immunodeficiency Virus (HIV) market. Human Immunodeficiency Virus (HIV) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Immunodeficiency Virus (HIV). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Immunodeficiency Virus (HIV) market.
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.
Key Features:
The report on Human Immunodeficiency Virus (HIV) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Human Immunodeficiency Virus (HIV) market. It may include historical data, market segmentation by Type (e.g., Diagnosis, Treatment), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Immunodeficiency Virus (HIV) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Immunodeficiency Virus (HIV) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Human Immunodeficiency Virus (HIV) industry. This include advancements in Human Immunodeficiency Virus (HIV) technology, Human Immunodeficiency Virus (HIV) new entrants, Human Immunodeficiency Virus (HIV) new investment, and other innovations that are shaping the future of Human Immunodeficiency Virus (HIV).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Immunodeficiency Virus (HIV) market. It includes factors influencing customer ' purchasing decisions, preferences for Human Immunodeficiency Virus (HIV) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Immunodeficiency Virus (HIV) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Immunodeficiency Virus (HIV) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Immunodeficiency Virus (HIV) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Immunodeficiency Virus (HIV) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Immunodeficiency Virus (HIV) market.
Market Segmentation:
Human Immunodeficiency Virus (HIV) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Diagnosis
- Treatment
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Homecare Settings
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gilead
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- AbbVie
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Genentech
- Cipla
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Immunodeficiency Virus (HIV) Market Size 2019-2030
2.1.2 Human Immunodeficiency Virus (HIV) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Human Immunodeficiency Virus (HIV) Segment by Type
2.2.1 Diagnosis
2.2.2 Treatment
2.3 Human Immunodeficiency Virus (HIV) Market Size by Type
2.3.1 Human Immunodeficiency Virus (HIV) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
2.4 Human Immunodeficiency Virus (HIV) Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Diagnostic Centers
2.4.4 Homecare Settings
2.4.5 Others
2.5 Human Immunodeficiency Virus (HIV) Market Size by Application
2.5.1 Human Immunodeficiency Virus (HIV) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
3 HUMAN IMMUNODEFICIENCY VIRUS (HIV) MARKET SIZE BY PLAYER
3.1 Human Immunodeficiency Virus (HIV) Market Size Market Share by Players
3.1.1 Global Human Immunodeficiency Virus (HIV) Revenue by Players (2019-2024)
3.1.2 Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Players (2019-2024)
3.2 Global Human Immunodeficiency Virus (HIV) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN IMMUNODEFICIENCY VIRUS (HIV) BY REGIONS
4.1 Human Immunodeficiency Virus (HIV) Market Size by Regions (2019-2024)
4.2 Americas Human Immunodeficiency Virus (HIV) Market Size Growth (2019-2024)
4.3 APAC Human Immunodeficiency Virus (HIV) Market Size Growth (2019-2024)
4.4 Europe Human Immunodeficiency Virus (HIV) Market Size Growth (2019-2024)
4.5 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Human Immunodeficiency Virus (HIV) Market Size by Country (2019-2024)
5.2 Americas Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024)
5.3 Americas Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Immunodeficiency Virus (HIV) Market Size by Region (2019-2024)
6.2 APAC Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024)
6.3 APAC Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Immunodeficiency Virus (HIV) by Country (2019-2024)
7.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024)
7.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Immunodeficiency Virus (HIV) by Region (2019-2024)
8.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024)
8.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN IMMUNODEFICIENCY VIRUS (HIV) MARKET FORECAST
10.1 Global Human Immunodeficiency Virus (HIV) Forecast by Regions (2025-2030)
10.1.1 Global Human Immunodeficiency Virus (HIV) Forecast by Regions (2025-2030)
10.1.2 Americas Human Immunodeficiency Virus (HIV) Forecast
10.1.3 APAC Human Immunodeficiency Virus (HIV) Forecast
10.1.4 Europe Human Immunodeficiency Virus (HIV) Forecast
10.1.5 Middle East & Africa Human Immunodeficiency Virus (HIV) Forecast
10.2 Americas Human Immunodeficiency Virus (HIV) Forecast by Country (2025-2030)
10.2.1 United States Human Immunodeficiency Virus (HIV) Market Forecast
10.2.2 Canada Human Immunodeficiency Virus (HIV) Market Forecast
10.2.3 Mexico Human Immunodeficiency Virus (HIV) Market Forecast
10.2.4 Brazil Human Immunodeficiency Virus (HIV) Market Forecast
10.3 APAC Human Immunodeficiency Virus (HIV) Forecast by Region (2025-2030)
10.3.1 China Human Immunodeficiency Virus (HIV) Market Forecast
10.3.2 Japan Human Immunodeficiency Virus (HIV) Market Forecast
10.3.3 Korea Human Immunodeficiency Virus (HIV) Market Forecast
10.3.4 Southeast Asia Human Immunodeficiency Virus (HIV) Market Forecast
10.3.5 India Human Immunodeficiency Virus (HIV) Market Forecast
10.3.6 Australia Human Immunodeficiency Virus (HIV) Market Forecast
10.4 Europe Human Immunodeficiency Virus (HIV) Forecast by Country (2025-2030)
10.4.1 Germany Human Immunodeficiency Virus (HIV) Market Forecast
10.4.2 France Human Immunodeficiency Virus (HIV) Market Forecast
10.4.3 UK Human Immunodeficiency Virus (HIV) Market Forecast
10.4.4 Italy Human Immunodeficiency Virus (HIV) Market Forecast
10.4.5 Russia Human Immunodeficiency Virus (HIV) Market Forecast
10.5 Middle East & Africa Human Immunodeficiency Virus (HIV) Forecast by Region (2025-2030)
10.5.1 Egypt Human Immunodeficiency Virus (HIV) Market Forecast
10.5.2 South Africa Human Immunodeficiency Virus (HIV) Market Forecast
10.5.3 Israel Human Immunodeficiency Virus (HIV) Market Forecast
10.5.4 Turkey Human Immunodeficiency Virus (HIV) Market Forecast
10.5.5 GCC Countries Human Immunodeficiency Virus (HIV) Market Forecast
10.6 Global Human Immunodeficiency Virus (HIV) Forecast by Type (2025-2030)
10.7 Global Human Immunodeficiency Virus (HIV) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Gilead
11.1.1 Gilead Company Information
11.1.2 Gilead Human Immunodeficiency Virus (HIV) Product Offered
11.1.3 Gilead Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Gilead Main Business Overview
11.1.5 Gilead Latest Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Product Offered
11.2.3 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GlaxoSmithKline Main Business Overview
11.2.5 GlaxoSmithKline Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Human Immunodeficiency Virus (HIV) Product Offered
11.3.3 Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Human Immunodeficiency Virus (HIV) Product Offered
11.4.3 Merck Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 AbbVie
11.5.1 AbbVie Company Information
11.5.2 AbbVie Human Immunodeficiency Virus (HIV) Product Offered
11.5.3 AbbVie Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AbbVie Main Business Overview
11.5.5 AbbVie Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Product Offered
11.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Information
11.7.2 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Product Offered
11.7.3 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Boehringer Ingelheim Main Business Overview
11.7.5 Boehringer Ingelheim Latest Developments
11.8 Genentech
11.8.1 Genentech Company Information
11.8.2 Genentech Human Immunodeficiency Virus (HIV) Product Offered
11.8.3 Genentech Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Genentech Main Business Overview
11.8.5 Genentech Latest Developments
11.9 Cipla
11.9.1 Cipla Company Information
11.9.2 Cipla Human Immunodeficiency Virus (HIV) Product Offered
11.9.3 Cipla Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cipla Main Business Overview
11.9.5 Cipla Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Immunodeficiency Virus (HIV) Market Size 2019-2030
2.1.2 Human Immunodeficiency Virus (HIV) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Human Immunodeficiency Virus (HIV) Segment by Type
2.2.1 Diagnosis
2.2.2 Treatment
2.3 Human Immunodeficiency Virus (HIV) Market Size by Type
2.3.1 Human Immunodeficiency Virus (HIV) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
2.4 Human Immunodeficiency Virus (HIV) Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Diagnostic Centers
2.4.4 Homecare Settings
2.4.5 Others
2.5 Human Immunodeficiency Virus (HIV) Market Size by Application
2.5.1 Human Immunodeficiency Virus (HIV) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
3 HUMAN IMMUNODEFICIENCY VIRUS (HIV) MARKET SIZE BY PLAYER
3.1 Human Immunodeficiency Virus (HIV) Market Size Market Share by Players
3.1.1 Global Human Immunodeficiency Virus (HIV) Revenue by Players (2019-2024)
3.1.2 Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Players (2019-2024)
3.2 Global Human Immunodeficiency Virus (HIV) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN IMMUNODEFICIENCY VIRUS (HIV) BY REGIONS
4.1 Human Immunodeficiency Virus (HIV) Market Size by Regions (2019-2024)
4.2 Americas Human Immunodeficiency Virus (HIV) Market Size Growth (2019-2024)
4.3 APAC Human Immunodeficiency Virus (HIV) Market Size Growth (2019-2024)
4.4 Europe Human Immunodeficiency Virus (HIV) Market Size Growth (2019-2024)
4.5 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Human Immunodeficiency Virus (HIV) Market Size by Country (2019-2024)
5.2 Americas Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024)
5.3 Americas Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Immunodeficiency Virus (HIV) Market Size by Region (2019-2024)
6.2 APAC Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024)
6.3 APAC Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Immunodeficiency Virus (HIV) by Country (2019-2024)
7.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024)
7.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Immunodeficiency Virus (HIV) by Region (2019-2024)
8.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024)
8.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN IMMUNODEFICIENCY VIRUS (HIV) MARKET FORECAST
10.1 Global Human Immunodeficiency Virus (HIV) Forecast by Regions (2025-2030)
10.1.1 Global Human Immunodeficiency Virus (HIV) Forecast by Regions (2025-2030)
10.1.2 Americas Human Immunodeficiency Virus (HIV) Forecast
10.1.3 APAC Human Immunodeficiency Virus (HIV) Forecast
10.1.4 Europe Human Immunodeficiency Virus (HIV) Forecast
10.1.5 Middle East & Africa Human Immunodeficiency Virus (HIV) Forecast
10.2 Americas Human Immunodeficiency Virus (HIV) Forecast by Country (2025-2030)
10.2.1 United States Human Immunodeficiency Virus (HIV) Market Forecast
10.2.2 Canada Human Immunodeficiency Virus (HIV) Market Forecast
10.2.3 Mexico Human Immunodeficiency Virus (HIV) Market Forecast
10.2.4 Brazil Human Immunodeficiency Virus (HIV) Market Forecast
10.3 APAC Human Immunodeficiency Virus (HIV) Forecast by Region (2025-2030)
10.3.1 China Human Immunodeficiency Virus (HIV) Market Forecast
10.3.2 Japan Human Immunodeficiency Virus (HIV) Market Forecast
10.3.3 Korea Human Immunodeficiency Virus (HIV) Market Forecast
10.3.4 Southeast Asia Human Immunodeficiency Virus (HIV) Market Forecast
10.3.5 India Human Immunodeficiency Virus (HIV) Market Forecast
10.3.6 Australia Human Immunodeficiency Virus (HIV) Market Forecast
10.4 Europe Human Immunodeficiency Virus (HIV) Forecast by Country (2025-2030)
10.4.1 Germany Human Immunodeficiency Virus (HIV) Market Forecast
10.4.2 France Human Immunodeficiency Virus (HIV) Market Forecast
10.4.3 UK Human Immunodeficiency Virus (HIV) Market Forecast
10.4.4 Italy Human Immunodeficiency Virus (HIV) Market Forecast
10.4.5 Russia Human Immunodeficiency Virus (HIV) Market Forecast
10.5 Middle East & Africa Human Immunodeficiency Virus (HIV) Forecast by Region (2025-2030)
10.5.1 Egypt Human Immunodeficiency Virus (HIV) Market Forecast
10.5.2 South Africa Human Immunodeficiency Virus (HIV) Market Forecast
10.5.3 Israel Human Immunodeficiency Virus (HIV) Market Forecast
10.5.4 Turkey Human Immunodeficiency Virus (HIV) Market Forecast
10.5.5 GCC Countries Human Immunodeficiency Virus (HIV) Market Forecast
10.6 Global Human Immunodeficiency Virus (HIV) Forecast by Type (2025-2030)
10.7 Global Human Immunodeficiency Virus (HIV) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Gilead
11.1.1 Gilead Company Information
11.1.2 Gilead Human Immunodeficiency Virus (HIV) Product Offered
11.1.3 Gilead Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Gilead Main Business Overview
11.1.5 Gilead Latest Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Product Offered
11.2.3 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GlaxoSmithKline Main Business Overview
11.2.5 GlaxoSmithKline Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Human Immunodeficiency Virus (HIV) Product Offered
11.3.3 Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Human Immunodeficiency Virus (HIV) Product Offered
11.4.3 Merck Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 AbbVie
11.5.1 AbbVie Company Information
11.5.2 AbbVie Human Immunodeficiency Virus (HIV) Product Offered
11.5.3 AbbVie Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AbbVie Main Business Overview
11.5.5 AbbVie Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Product Offered
11.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Information
11.7.2 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Product Offered
11.7.3 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Boehringer Ingelheim Main Business Overview
11.7.5 Boehringer Ingelheim Latest Developments
11.8 Genentech
11.8.1 Genentech Company Information
11.8.2 Genentech Human Immunodeficiency Virus (HIV) Product Offered
11.8.3 Genentech Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Genentech Main Business Overview
11.8.5 Genentech Latest Developments
11.9 Cipla
11.9.1 Cipla Company Information
11.9.2 Cipla Human Immunodeficiency Virus (HIV) Product Offered
11.9.3 Cipla Human Immunodeficiency Virus (HIV) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cipla Main Business Overview
11.9.5 Cipla Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Immunodeficiency Virus (HIV) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Diagnosis
Table 3. Major Players of Treatment
Table 4. Human Immunodeficiency Virus (HIV) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Table 7. Human Immunodeficiency Virus (HIV) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Table 10. Global Human Immunodeficiency Virus (HIV) Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Player (2019-2024)
Table 12. Human Immunodeficiency Virus (HIV) Key Players Head office and Products Offered
Table 13. Human Immunodeficiency Virus (HIV) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Human Immunodeficiency Virus (HIV) Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Regions (2019-2024)
Table 18. Global Human Immunodeficiency Virus (HIV) Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Human Immunodeficiency Virus (HIV) Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Human Immunodeficiency Virus (HIV) Market Size Market Share by Country (2019-2024)
Table 22. Americas Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Table 24. Americas Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Table 26. APAC Human Immunodeficiency Virus (HIV) Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Region (2019-2024)
Table 28. APAC Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Table 30. APAC Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Table 32. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Country (2019-2024)
Table 34. Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Table 36. Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Human Immunodeficiency Virus (HIV)
Table 45. Key Market Challenges & Risks of Human Immunodeficiency Virus (HIV)
Table 46. Key Industry Trends of Human Immunodeficiency Virus (HIV)
Table 47. Global Human Immunodeficiency Virus (HIV) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Human Immunodeficiency Virus (HIV) Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Human Immunodeficiency Virus (HIV) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Human Immunodeficiency Virus (HIV) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Gilead Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 52. Gilead Human Immunodeficiency Virus (HIV) Product Offered
Table 53. Gilead Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Gilead Main Business
Table 55. Gilead Latest Developments
Table 56. GlaxoSmithKline Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 57. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Product Offered
Table 58. GlaxoSmithKline Main Business
Table 59. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. GlaxoSmithKline Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 62. Johnson & Johnson Human Immunodeficiency Virus (HIV) Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Johnson & Johnson Latest Developments
Table 66. Merck Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 67. Merck Human Immunodeficiency Virus (HIV) Product Offered
Table 68. Merck Main Business
Table 69. Merck Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Merck Latest Developments
Table 71. AbbVie Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 72. AbbVie Human Immunodeficiency Virus (HIV) Product Offered
Table 73. AbbVie Main Business
Table 74. AbbVie Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. AbbVie Latest Developments
Table 76. Bristol-Myers Squibb Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 77. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Product Offered
Table 78. Bristol-Myers Squibb Main Business
Table 79. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Bristol-Myers Squibb Latest Developments
Table 81. Boehringer Ingelheim Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 82. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Product Offered
Table 83. Boehringer Ingelheim Main Business
Table 84. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Boehringer Ingelheim Latest Developments
Table 86. Genentech Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 87. Genentech Human Immunodeficiency Virus (HIV) Product Offered
Table 88. Genentech Main Business
Table 89. Genentech Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Genentech Latest Developments
Table 91. Cipla Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 92. Cipla Human Immunodeficiency Virus (HIV) Product Offered
Table 93. Cipla Main Business
Table 94. Cipla Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Cipla Latest Developments
Table 1. Human Immunodeficiency Virus (HIV) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Diagnosis
Table 3. Major Players of Treatment
Table 4. Human Immunodeficiency Virus (HIV) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Table 7. Human Immunodeficiency Virus (HIV) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Table 10. Global Human Immunodeficiency Virus (HIV) Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Player (2019-2024)
Table 12. Human Immunodeficiency Virus (HIV) Key Players Head office and Products Offered
Table 13. Human Immunodeficiency Virus (HIV) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Human Immunodeficiency Virus (HIV) Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Regions (2019-2024)
Table 18. Global Human Immunodeficiency Virus (HIV) Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Human Immunodeficiency Virus (HIV) Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Human Immunodeficiency Virus (HIV) Market Size Market Share by Country (2019-2024)
Table 22. Americas Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Table 24. Americas Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Table 26. APAC Human Immunodeficiency Virus (HIV) Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Region (2019-2024)
Table 28. APAC Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Table 30. APAC Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Table 32. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Country (2019-2024)
Table 34. Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Table 36. Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Human Immunodeficiency Virus (HIV)
Table 45. Key Market Challenges & Risks of Human Immunodeficiency Virus (HIV)
Table 46. Key Industry Trends of Human Immunodeficiency Virus (HIV)
Table 47. Global Human Immunodeficiency Virus (HIV) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Human Immunodeficiency Virus (HIV) Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Human Immunodeficiency Virus (HIV) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Human Immunodeficiency Virus (HIV) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Gilead Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 52. Gilead Human Immunodeficiency Virus (HIV) Product Offered
Table 53. Gilead Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Gilead Main Business
Table 55. Gilead Latest Developments
Table 56. GlaxoSmithKline Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 57. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Product Offered
Table 58. GlaxoSmithKline Main Business
Table 59. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. GlaxoSmithKline Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 62. Johnson & Johnson Human Immunodeficiency Virus (HIV) Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Johnson & Johnson Latest Developments
Table 66. Merck Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 67. Merck Human Immunodeficiency Virus (HIV) Product Offered
Table 68. Merck Main Business
Table 69. Merck Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Merck Latest Developments
Table 71. AbbVie Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 72. AbbVie Human Immunodeficiency Virus (HIV) Product Offered
Table 73. AbbVie Main Business
Table 74. AbbVie Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. AbbVie Latest Developments
Table 76. Bristol-Myers Squibb Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 77. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Product Offered
Table 78. Bristol-Myers Squibb Main Business
Table 79. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Bristol-Myers Squibb Latest Developments
Table 81. Boehringer Ingelheim Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 82. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Product Offered
Table 83. Boehringer Ingelheim Main Business
Table 84. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Boehringer Ingelheim Latest Developments
Table 86. Genentech Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 87. Genentech Human Immunodeficiency Virus (HIV) Product Offered
Table 88. Genentech Main Business
Table 89. Genentech Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Genentech Latest Developments
Table 91. Cipla Details, Company Type, Human Immunodeficiency Virus (HIV) Area Served and Its Competitors
Table 92. Cipla Human Immunodeficiency Virus (HIV) Product Offered
Table 93. Cipla Main Business
Table 94. Cipla Human Immunodeficiency Virus (HIV) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Cipla Latest Developments
LIST OF FIGURES
Figure 1. Human Immunodeficiency Virus (HIV) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Human Immunodeficiency Virus (HIV) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Human Immunodeficiency Virus (HIV) Sales Market Share by Country/Region (2023)
Figure 8. Human Immunodeficiency Virus (HIV) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Type in 2023
Figure 10. Human Immunodeficiency Virus (HIV) in Hospitals
Figure 11. Global Human Immunodeficiency Virus (HIV) Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Human Immunodeficiency Virus (HIV) in Ambulatory Surgical Centers
Figure 13. Global Human Immunodeficiency Virus (HIV) Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 14. Human Immunodeficiency Virus (HIV) in Diagnostic Centers
Figure 15. Global Human Immunodeficiency Virus (HIV) Market: Diagnostic Centers (2019-2024) & ($ Millions)
Figure 16. Human Immunodeficiency Virus (HIV) in Homecare Settings
Figure 17. Global Human Immunodeficiency Virus (HIV) Market: Homecare Settings (2019-2024) & ($ Millions)
Figure 18. Human Immunodeficiency Virus (HIV) in Others
Figure 19. Global Human Immunodeficiency Virus (HIV) Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Application in 2023
Figure 21. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Player in 2023
Figure 22. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Human Immunodeficiency Virus (HIV) Market Size 2019-2024 ($ Millions)
Figure 24. APAC Human Immunodeficiency Virus (HIV) Market Size 2019-2024 ($ Millions)
Figure 25. Europe Human Immunodeficiency Virus (HIV) Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size 2019-2024 ($ Millions)
Figure 27. Americas Human Immunodeficiency Virus (HIV) Value Market Share by Country in 2023
Figure 28. United States Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Region in 2023
Figure 33. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Type in 2023
Figure 34. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Application in 2023
Figure 35. China Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Country in 2023
Figure 42. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Figure 43. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Figure 44. Germany Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 58. APAC Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 59. Europe Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 61. United States Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 62. Canada Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 65. China Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 66. Japan Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 67. Korea Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 69. India Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 70. Australia Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 71. Germany Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 72. France Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 73. UK Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 74. Italy Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 75. Russia Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 76. Spain Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 79. Israel Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 82. Global Human Immunodeficiency Virus (HIV) Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Human Immunodeficiency Virus (HIV) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Human Immunodeficiency Virus (HIV) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Human Immunodeficiency Virus (HIV) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Human Immunodeficiency Virus (HIV) Sales Market Share by Country/Region (2023)
Figure 8. Human Immunodeficiency Virus (HIV) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Type in 2023
Figure 10. Human Immunodeficiency Virus (HIV) in Hospitals
Figure 11. Global Human Immunodeficiency Virus (HIV) Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Human Immunodeficiency Virus (HIV) in Ambulatory Surgical Centers
Figure 13. Global Human Immunodeficiency Virus (HIV) Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 14. Human Immunodeficiency Virus (HIV) in Diagnostic Centers
Figure 15. Global Human Immunodeficiency Virus (HIV) Market: Diagnostic Centers (2019-2024) & ($ Millions)
Figure 16. Human Immunodeficiency Virus (HIV) in Homecare Settings
Figure 17. Global Human Immunodeficiency Virus (HIV) Market: Homecare Settings (2019-2024) & ($ Millions)
Figure 18. Human Immunodeficiency Virus (HIV) in Others
Figure 19. Global Human Immunodeficiency Virus (HIV) Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Application in 2023
Figure 21. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Player in 2023
Figure 22. Global Human Immunodeficiency Virus (HIV) Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Human Immunodeficiency Virus (HIV) Market Size 2019-2024 ($ Millions)
Figure 24. APAC Human Immunodeficiency Virus (HIV) Market Size 2019-2024 ($ Millions)
Figure 25. Europe Human Immunodeficiency Virus (HIV) Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size 2019-2024 ($ Millions)
Figure 27. Americas Human Immunodeficiency Virus (HIV) Value Market Share by Country in 2023
Figure 28. United States Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Region in 2023
Figure 33. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Type in 2023
Figure 34. APAC Human Immunodeficiency Virus (HIV) Market Size Market Share by Application in 2023
Figure 35. China Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Country in 2023
Figure 42. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Figure 43. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Figure 44. Germany Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Human Immunodeficiency Virus (HIV) Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 58. APAC Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 59. Europe Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 61. United States Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 62. Canada Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 65. China Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 66. Japan Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 67. Korea Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 69. India Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 70. Australia Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 71. Germany Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 72. France Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 73. UK Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 74. Italy Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 75. Russia Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 76. Spain Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 79. Israel Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Human Immunodeficiency Virus (HIV) Market Size 2025-2030 ($ Millions)
Figure 82. Global Human Immunodeficiency Virus (HIV) Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Human Immunodeficiency Virus (HIV) Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Veterinary Care Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
102 pages
Global Radiation Protective Caps Market Growth 2024-2030
US$ 3,660.00
September 2024
111 pages
Global Electronic Aspirin Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
76 pages
Global Limulus Amebocyte Lysate Market Growth 2023-2029
US$ 3,660.00
February 2023
96 pages
Global Animal Insulin Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
80 pages
